2025-09-10 |
SCHEDULE 13G/A |
MEIP
/ MEI Pharma
|
Schornstein Alexander
|
2,115,000 |
4,365,472 |
106.41 |
2025-09-10 |
NPORT-P |
PBH
/ Prestige Consumer Healthcare
|
NCLEX - NICHOLAS Ltd EDITION, INC. - NICHOLAS LTD EDITION INC CLASS I
|
149,595 |
149,595 |
0.00 |
2025-09-10 |
SCHEDULE 13G |
SCPH
/ scPharmaceuticals
|
Glazer Capital, Llc
|
2,474,820 |
2,474,820 |
0.00 |
2025-09-10 |
NPORT-P |
SEE
/ Sealed Air
|
VVPSX - FINANCIAL INVESTORS TRUST - Vulcan Value Partners Small Cap Fund Investor Class Shares
|
176,338 |
166,338 |
-5.67 |
2025-09-10 |
13F-HR/A |
PG
/ Procter & Gamble
|
Troy Asset Management Ltd
|
1,861,917 |
0 |
-100.00 |
2025-09-10 |
13F-HR/A |
KVUE
/ Kenvue
|
Troy Asset Management Ltd
|
726,520 |
0 |
-100.00 |
2025-09-10 |
13F-HR/A |
CL
/ Colgate-Palmolive
|
Troy Asset Management Ltd
|
13,875 |
0 |
-100.00 |
2025-09-10 |
13F-HR/A |
JNJ
/ Johnson & Johnson
|
Troy Asset Management Ltd
|
298,894 |
0 |
-100.00 |
2025-09-10 |
13F-HR/A |
CLX
/ Clorox
|
Troy Asset Management Ltd
|
129,355 |
0 |
-100.00 |
2025-09-10 |
13F-HR/A |
JNJ
/ Johnson & Johnson
|
Troy Asset Management Ltd
|
375,742 |
0 |
-100.00 |
2025-09-10 |
13F-HR/A |
PG
/ Procter & Gamble
|
Troy Asset Management Ltd
|
1,966,158 |
0 |
-100.00 |
2025-09-10 |
13F-HR/A |
CL
/ Colgate-Palmolive
|
Troy Asset Management Ltd
|
14,041 |
0 |
-100.00 |
2025-09-10 |
13F-HR/A |
CLX
/ Clorox
|
Troy Asset Management Ltd
|
125,197 |
0 |
-100.00 |
2025-09-10 |
NPORT-P |
ABT
/ Abbott Laboratories
|
LFTPX - Lincoln Funds Trust - Lincoln U.S. Equity Income Maximizer Fund Class I
|
1,291 |
1,291 |
0.00 |
2025-09-10 |
NPORT-P |
ABBV
/ AbbVie
|
LFTPX - Lincoln Funds Trust - Lincoln U.S. Equity Income Maximizer Fund Class I
|
778 |
778 |
0.00 |
2025-09-10 |
NPORT-P |
PG
/ Procter & Gamble
|
LFTPX - Lincoln Funds Trust - Lincoln U.S. Equity Income Maximizer Fund Class I
|
1,039 |
1,039 |
0.00 |
2025-09-10 |
NPORT-P |
PFE
/ Pfizer
|
LFTPX - Lincoln Funds Trust - Lincoln U.S. Equity Income Maximizer Fund Class I
|
3,125 |
3,125 |
0.00 |
2025-09-10 |
NPORT-P |
LIN
/ Linde
|
LFTPX - Lincoln Funds Trust - Lincoln U.S. Equity Income Maximizer Fund Class I
|
336 |
336 |
0.00 |
2025-09-10 |
NPORT-P |
JNJ
/ Johnson & Johnson
|
LFTPX - Lincoln Funds Trust - Lincoln U.S. Equity Income Maximizer Fund Class I
|
1,405 |
1,405 |
0.00 |
2025-09-10 |
NPORT-P |
AMGN
/ Amgen
|
LFTPX - Lincoln Funds Trust - Lincoln U.S. Equity Income Maximizer Fund Class I
|
264 |
264 |
0.00 |
2025-09-10 |
NPORT-P |
LLY
/ Eli Lilly and
|
LFTPX - Lincoln Funds Trust - Lincoln U.S. Equity Income Maximizer Fund Class I
|
258 |
258 |
0.00 |
2025-09-10 |
NPORT-P |
MRK
/ Merck
|
LFTPX - Lincoln Funds Trust - Lincoln U.S. Equity Income Maximizer Fund Class I
|
960 |
960 |
0.00 |
2025-09-10 |
13F-HR/A |
CL
/ Colgate-Palmolive
|
Troy Asset Management Ltd
|
1,554,607 |
0 |
-100.00 |
2025-09-10 |
13F-HR/A |
CLX
/ Clorox
|
Troy Asset Management Ltd
|
55,200 |
0 |
-100.00 |
2025-09-10 |
13F-HR/A |
PFE
/ Pfizer
|
Troy Asset Management Ltd
|
33,000 |
0 |
-100.00 |
2025-09-10 |
13F-HR/A |
JNJ
/ Johnson & Johnson
|
Troy Asset Management Ltd
|
127,612 |
0 |
-100.00 |
2025-09-10 |
13F-HR/A |
PG
/ Procter & Gamble
|
Troy Asset Management Ltd
|
2,608,738 |
0 |
-100.00 |
2025-09-10 |
13F-HR/A |
PG
/ Procter & Gamble
|
Troy Asset Management Ltd
|
2,552,935 |
0 |
-100.00 |
2025-09-10 |
13F-HR/A |
CL
/ Colgate-Palmolive
|
Troy Asset Management Ltd
|
1,466,007 |
0 |
-100.00 |
2025-09-10 |
13F-HR/A |
PFE
/ Pfizer
|
Troy Asset Management Ltd
|
33,000 |
0 |
-100.00 |
2025-09-10 |
13F-HR/A |
JNJ
/ Johnson & Johnson
|
Troy Asset Management Ltd
|
127,274 |
0 |
-100.00 |
2025-09-10 |
13F-HR/A |
CLX
/ Clorox
|
Troy Asset Management Ltd
|
45,000 |
0 |
-100.00 |
2025-09-09 |
SCHEDULE 13D/A |
VOR
/ Vor Biopharma
|
Reprogrammed Interchange LLC
|
36,884,567 |
35,476,939 |
-3.82 |
2025-09-09 |
SCHEDULE 13G |
PPBT
/ Purple Biotech Ltd - Depositary Receipt ()
|
Lincoln Alternative Strategies LLC
|
|
605,000 |
|
2025-09-09 |
13F-HR |
JNJ
/ Johnson & Johnson
|
Cambridge Financial Group, LLC
|
4,578 |
4,324 |
-5.55 |
2025-09-09 |
13F-HR |
ABBV
/ AbbVie
|
Cambridge Financial Group, LLC
|
2,694 |
2,503 |
-7.09 |
2025-09-09 |
13F-HR |
PG
/ Procter & Gamble
|
Cambridge Financial Group, LLC
|
3,046 |
2,308 |
-24.23 |
2025-09-09 |
13F-HR |
CL
/ Colgate-Palmolive
|
Cambridge Financial Group, LLC
|
3,350 |
3,602 |
7.52 |
2025-09-09 |
13F-HR |
LLY
/ Eli Lilly and
|
Cambridge Financial Group, LLC
|
1,139 |
876 |
-23.09 |
2025-09-09 |
13F-HR |
MRK
/ Merck
|
Cambridge Financial Group, LLC
|
4,452 |
3,812 |
-14.38 |
2025-09-09 |
13F-HR |
DD
/ DuPont de Nemours
|
Cambridge Financial Group, LLC
|
3,313 |
0 |
-100.00 |
2025-09-09 |
13F-HR |
ABBV
/ AbbVie
|
Cambridge Financial Group, LLC
|
2,315 |
2,314 |
-0.04 |
2025-09-09 |
13F-HR |
JNJ
/ Johnson & Johnson
|
Cambridge Financial Group, LLC
|
5,514 |
5,462 |
-0.94 |
2025-09-09 |
13F-HR |
LLY
/ Eli Lilly and
|
Cambridge Financial Group, LLC
|
1,127 |
1,051 |
-6.74 |
2025-09-09 |
13F-HR |
MRK
/ Merck
|
Cambridge Financial Group, LLC
|
5,238 |
4,858 |
-7.25 |
2025-09-09 |
13F-HR |
DD
/ DuPont de Nemours
|
Cambridge Financial Group, LLC
|
3,541 |
3,919 |
10.67 |
2025-09-09 |
13F-HR |
CL
/ Colgate-Palmolive
|
Cambridge Financial Group, LLC
|
3,350 |
3,350 |
0.00 |
2025-09-09 |
13F-HR |
PG
/ Procter & Gamble
|
Cambridge Financial Group, LLC
|
2,571 |
2,359 |
-8.25 |
2025-09-09 |
13F-HR |
ZTS
/ Zoetis
|
Cambridge Financial Group, LLC
|
1,035 |
0 |
-100.00 |
2025-09-09 |
13F-HR |
DOW
/ Dow
|
Cambridge Financial Group, LLC
|
4,022 |
0 |
-100.00 |
2025-09-09 |
13F-HR |
ABBV
/ AbbVie
|
Cambridge Financial Group, LLC
|
2,314 |
2,534 |
9.51 |
2025-09-09 |
13F-HR |
JNJ
/ Johnson & Johnson
|
Cambridge Financial Group, LLC
|
5,381 |
4,555 |
-15.35 |
2025-09-09 |
13F-HR |
PG
/ Procter & Gamble
|
Cambridge Financial Group, LLC
|
2,370 |
2,633 |
11.10 |
2025-09-09 |
13F-HR |
CL
/ Colgate-Palmolive
|
Cambridge Financial Group, LLC
|
3,350 |
3,350 |
0.00 |
2025-09-09 |
13F-HR |
LLY
/ Eli Lilly and
|
Cambridge Financial Group, LLC
|
1,059 |
1,169 |
10.39 |
2025-09-09 |
13F-HR |
MRK
/ Merck
|
Cambridge Financial Group, LLC
|
4,860 |
5,113 |
5.21 |
2025-09-09 |
13F-HR |
DD
/ DuPont de Nemours
|
Cambridge Financial Group, LLC
|
3,918 |
3,918 |
0.00 |
2025-09-09 |
13F-HR |
ABT
/ Abbott Laboratories
|
Cambridge Financial Group, LLC
|
|
1,767 |
|
2025-09-09 |
13F-HR |
ZTS
/ Zoetis
|
Cambridge Financial Group, LLC
|
0 |
1,039 |
|
2025-09-09 |
13F-HR |
JNJ
/ Johnson & Johnson
|
Cambridge Financial Group, LLC
|
4,555 |
4,511 |
-0.97 |
2025-09-09 |
13F-HR |
CL
/ Colgate-Palmolive
|
Cambridge Financial Group, LLC
|
3,350 |
3,350 |
0.00 |
2025-09-09 |
13F-HR |
PG
/ Procter & Gamble
|
Cambridge Financial Group, LLC
|
2,633 |
2,637 |
0.15 |
2025-09-09 |
13F-HR |
ABBV
/ AbbVie
|
Cambridge Financial Group, LLC
|
2,534 |
2,480 |
-2.13 |
2025-09-09 |
13F-HR |
LLY
/ Eli Lilly and
|
Cambridge Financial Group, LLC
|
1,169 |
1,139 |
-2.57 |
2025-09-09 |
13F-HR |
MRK
/ Merck
|
Cambridge Financial Group, LLC
|
5,113 |
5,209 |
1.88 |
2025-09-09 |
13F-HR |
DD
/ DuPont de Nemours
|
Cambridge Financial Group, LLC
|
3,918 |
3,313 |
-15.44 |
2025-09-09 |
13F-HR |
ABT
/ Abbott Laboratories
|
Cambridge Financial Group, LLC
|
1,767 |
0 |
-100.00 |
2025-09-09 |
13F-HR |
ZTS
/ Zoetis
|
Cambridge Financial Group, LLC
|
1,039 |
0 |
-100.00 |
2025-09-09 |
13F-HR |
JNJ
/ Johnson & Johnson
|
Cambridge Financial Group, LLC
|
4,511 |
4,578 |
1.49 |
2025-09-09 |
13F-HR |
ABBV
/ AbbVie
|
Cambridge Financial Group, LLC
|
2,480 |
2,694 |
8.63 |
2025-09-09 |
13F-HR |
PG
/ Procter & Gamble
|
Cambridge Financial Group, LLC
|
2,637 |
3,046 |
15.51 |
2025-09-09 |
13F-HR |
LLY
/ Eli Lilly and
|
Cambridge Financial Group, LLC
|
1,139 |
1,139 |
0.00 |
2025-09-09 |
13F-HR |
MRK
/ Merck
|
Cambridge Financial Group, LLC
|
5,209 |
4,452 |
-14.53 |
2025-09-09 |
13F-HR |
DD
/ DuPont de Nemours
|
Cambridge Financial Group, LLC
|
3,313 |
3,313 |
0.00 |
2025-09-09 |
13F-HR |
CL
/ Colgate-Palmolive
|
Cambridge Financial Group, LLC
|
3,350 |
3,350 |
0.00 |
2025-09-09 |
13F-HR |
ABBV
/ AbbVie
|
Cambridge Financial Group, LLC
|
2,314 |
2,314 |
0.00 |
2025-09-09 |
13F-HR |
JNJ
/ Johnson & Johnson
|
Cambridge Financial Group, LLC
|
5,462 |
5,381 |
-1.48 |
2025-09-09 |
13F-HR |
PG
/ Procter & Gamble
|
Cambridge Financial Group, LLC
|
2,359 |
2,370 |
0.47 |
2025-09-09 |
13F-HR |
MRK
/ Merck
|
Cambridge Financial Group, LLC
|
4,858 |
4,860 |
0.04 |
2025-09-09 |
13F-HR |
DD
/ DuPont de Nemours
|
Cambridge Financial Group, LLC
|
3,919 |
3,918 |
-0.03 |
2025-09-09 |
13F-HR |
CL
/ Colgate-Palmolive
|
Cambridge Financial Group, LLC
|
3,350 |
3,350 |
0.00 |
2025-09-09 |
13F-HR |
LLY
/ Eli Lilly and
|
Cambridge Financial Group, LLC
|
1,051 |
1,059 |
0.76 |
2025-09-09 |
13F-HR |
MRK
/ Merck
|
Cambridge Financial Group, LLC
|
|
5,238 |
|
2025-09-09 |
13F-HR |
DD
/ DuPont de Nemours
|
Cambridge Financial Group, LLC
|
|
3,541 |
|
2025-09-09 |
13F-HR |
JNJ
/ Johnson & Johnson
|
Cambridge Financial Group, LLC
|
|
5,514 |
|
2025-09-09 |
13F-HR |
CL
/ Colgate-Palmolive
|
Cambridge Financial Group, LLC
|
|
3,350 |
|
2025-09-09 |
13F-HR |
PG
/ Procter & Gamble
|
Cambridge Financial Group, LLC
|
|
2,571 |
|
2025-09-09 |
13F-HR |
ABBV
/ AbbVie
|
Cambridge Financial Group, LLC
|
|
2,315 |
|
2025-09-09 |
13F-HR |
LLY
/ Eli Lilly and
|
Cambridge Financial Group, LLC
|
|
1,127 |
|
2025-09-09 |
13F-HR |
ZTS
/ Zoetis
|
Cambridge Financial Group, LLC
|
|
1,035 |
|
2025-09-09 |
13F-HR |
DOW
/ Dow
|
Cambridge Financial Group, LLC
|
|
4,022 |
|
2025-09-09 |
SCHEDULE 13G |
SCPH
/ scPharmaceuticals
|
Glazer Capital, Llc
|
|
2,474,820 |
|
2025-09-09 |
SCHEDULE 13G/A |
CALC
/ CalciMedica
|
Avenue Venture Opportunities Fund II, L.P.
|
1,359,553 |
1,359,553 |
0.00 |
2025-09-09 |
SCHEDULE 13G/A |
PPBT
/ Purple Biotech Ltd - Depositary Receipt ()
|
Orca Capital AG
|
|
306,394 |
|
2025-09-09 |
SCHEDULE 13G |
PPBT
/ Purple Biotech Ltd - Depositary Receipt ()
|
Orca Capital AG
|
|
605,000 |
|
2025-09-09 |
13F-HR/A |
MRNA
/ Moderna
|
Banque Transatlantique SA
|
69,708 |
34,205 |
-50.93 |
2025-09-09 |
13F-HR/A |
ABBV
/ AbbVie
|
Banque Transatlantique SA
|
1,200 |
1,200 |
0.00 |
2025-09-09 |
13F-HR/A |
JNJ
/ Johnson & Johnson
|
Banque Transatlantique SA
|
88,582 |
81,293 |
-8.23 |
2025-09-09 |
13F-HR/A |
NVAX
/ Novavax
|
Banque Transatlantique SA
|
120 |
120 |
0.00 |
2025-09-09 |
13F-HR/A |
PG
/ Procter & Gamble
|
Banque Transatlantique SA
|
11,905 |
11,935 |
0.25 |
2025-09-09 |
13F-HR/A |
ESPR
/ Esperion Therapeutics
|
Banque Transatlantique SA
|
260 |
260 |
0.00 |
2025-09-09 |
13F-HR/A |
APD
/ Air Products and Chemicals
|
Banque Transatlantique SA
|
5,644 |
5,233 |
-7.28 |
2025-09-09 |
13F-HR/A |
DOW
/ Dow
|
Banque Transatlantique SA
|
244 |
244 |
0.00 |
2025-09-09 |
13F-HR/A |
BMY
/ Bristol-Myers Squibb
|
Banque Transatlantique SA
|
1,970 |
1,970 |
0.00 |
2025-09-09 |
13F-HR/A |
NVO
/ Novo Nordisk A
|
Banque Transatlantique SA
|
4,810 |
2,830 |
-41.16 |
2025-09-09 |
13F-HR/A |
CL
/ Colgate-Palmolive
|
Banque Transatlantique SA
|
245 |
245 |
0.00 |
2025-09-09 |
13F-HR/A |
ZTS
/ Zoetis
|
Banque Transatlantique SA
|
485,123 |
502,679 |
3.62 |
2025-09-09 |
13F-HR/A |
ABT
/ Abbott Laboratories
|
Banque Transatlantique SA
|
38,104 |
18,804 |
-50.65 |
2025-09-09 |
13F-HR/A |
AMGN
/ Amgen
|
Banque Transatlantique SA
|
1,712 |
1,712 |
0.00 |
2025-09-09 |
13F-HR/A |
OGN
/ Organon
|
Banque Transatlantique SA
|
135 |
115 |
-14.81 |
2025-09-09 |
13F-HR/A |
REGN
/ Regeneron Pharmaceuticals
|
Banque Transatlantique SA
|
1,600 |
354 |
-77.88 |
2025-09-09 |
13F-HR/A |
DD
/ DuPont de Nemours
|
Banque Transatlantique SA
|
261 |
261 |
0.00 |
2025-09-09 |
13F-HR/A |
ATRA
/ Atara Biotherapeutics
|
Banque Transatlantique SA
|
176 |
176 |
0.00 |
2025-09-09 |
13F-HR/A |
LLY
/ Eli Lilly and
|
Banque Transatlantique SA
|
138,230 |
130,418 |
-5.65 |
2025-09-09 |
13F-HR/A |
AZN
/ AstraZeneca PLC - Depositary Receipt ()
|
Banque Transatlantique SA
|
402 |
402 |
0.00 |
2025-09-09 |
13F-HR/A |
PFE
/ Pfizer
|
Banque Transatlantique SA
|
67,006 |
63,856 |
-4.70 |
2025-09-09 |
13F-HR/A |
LIN
/ Linde
|
Banque Transatlantique SA
|
86,079 |
72,725 |
-15.51 |
2025-09-09 |
13F-HR/A |
EL
/ Estée Lauder Companies
|
Banque Transatlantique SA
|
3,976 |
3,321 |
-16.47 |
2025-09-09 |
13F-HR/A |
HXL
/ Hexcel
|
Banque Transatlantique SA
|
21 |
21 |
0.00 |
2025-09-09 |
13F-HR/A |
IDXX
/ IDEXX Laboratories
|
Banque Transatlantique SA
|
6,491 |
5,197 |
-19.94 |
2025-09-09 |
13F-HR/A |
RXRX
/ Recursion Pharmaceuticals
|
Banque Transatlantique SA
|
924 |
924 |
0.00 |
2025-09-09 |
13F-HR/A |
TWST
/ Twist Bioscience
|
Banque Transatlantique SA
|
900 |
900 |
0.00 |
2025-09-09 |
13F-HR/A |
VRTX
/ Vertex Pharmaceuticals
|
Banque Transatlantique SA
|
612 |
824 |
34.64 |
2025-09-09 |
13F-HR/A |
ECL
/ Ecolab
|
Banque Transatlantique SA
|
36 |
36 |
0.00 |
2025-09-09 |
13F-HR/A |
MRK
/ Merck
|
Banque Transatlantique SA
|
25,311 |
23,633 |
-6.63 |
2025-09-09 |
13F-HR/A |
VTRS
/ Viatris
|
Banque Transatlantique SA
|
4,403 |
4,403 |
0.00 |
2025-09-09 |
13F-HR/A |
TGTX
/ TG Therapeutics
|
Banque Transatlantique SA
|
|
15,468 |
|
2025-09-09 |
13F-HR/A |
COTY
/ Coty
|
Banque Transatlantique SA
|
1,000 |
0 |
-100.00 |
2025-09-09 |
13F-HR/A |
KVUE
/ Kenvue
|
Banque Transatlantique SA
|
201 |
0 |
-100.00 |
2025-09-09 |
13F-HR/A |
CHD
/ Church & Dwight
|
Banque Transatlantique SA
|
446 |
0 |
-100.00 |
2025-09-09 |
13F-HR |
BMY
/ Bristol-Myers Squibb
|
NWF Advisory Services Inc.
|
6,539 |
6,641 |
1.56 |
2025-09-09 |
13F-HR |
GILD
/ Gilead Sciences
|
NWF Advisory Services Inc.
|
1,863 |
2,162 |
16.05 |
2025-09-09 |
13F-HR |
PG
/ Procter & Gamble
|
NWF Advisory Services Inc.
|
5,378 |
6,223 |
15.71 |
2025-09-09 |
13F-HR |
MRK
/ Merck
|
NWF Advisory Services Inc.
|
8,073 |
16,850 |
108.72 |
2025-09-09 |
13F-HR |
LOOP
/ Loop Industries
|
NWF Advisory Services Inc.
|
167,616 |
167,616 |
0.00 |
2025-09-09 |
13F-HR |
PFE
/ Pfizer
|
NWF Advisory Services Inc.
|
36,494 |
37,656 |
3.18 |
2025-09-09 |
13F-HR |
AMGN
/ Amgen
|
NWF Advisory Services Inc.
|
5,760 |
5,804 |
0.76 |
2025-09-09 |
13F-HR |
LLY
/ Eli Lilly and
|
NWF Advisory Services Inc.
|
972 |
1,974 |
103.09 |
2025-09-09 |
13F-HR |
ABBV
/ AbbVie
|
NWF Advisory Services Inc.
|
9,565 |
13,504 |
41.18 |
2025-09-09 |
13F-HR |
JNJ
/ Johnson & Johnson
|
NWF Advisory Services Inc.
|
5,809 |
9,850 |
69.56 |
2025-09-09 |
13F-HR |
AZN
/ AstraZeneca PLC - Depositary Receipt ()
|
NWF Advisory Services Inc.
|
|
8,678 |
|
2025-09-09 |
13F-HR |
LIN
/ Linde
|
NWF Advisory Services Inc.
|
|
2,141 |
|
2025-09-09 |
13F-HR |
ABT
/ Abbott Laboratories
|
NWF Advisory Services Inc.
|
9,507 |
12,043 |
26.68 |
2025-09-09 |
13F-HR |
NVO
/ Novo Nordisk A
|
NWF Advisory Services Inc.
|
|
7,818 |
|
2025-09-09 |
13F-HR |
CL
/ Colgate-Palmolive
|
NWF Advisory Services Inc.
|
8,211 |
8,261 |
0.61 |
2025-09-08 |
SCHEDULE 13D/A |
MLYS
/ Mineralys Therapeutics
|
Samsara BioCapital, L.P.
|
5,736,305 |
6,346,194 |
10.63 |
2025-09-08 |
SCHEDULE 13D/A |
MLYS
/ Mineralys Therapeutics
|
Ra Capital Management, L.p.
|
6,287,597 |
7,796,433 |
24.00 |
2025-09-08 |
SCHEDULE 13G |
VTVT
/ vTv Therapeutics
|
Trails Edge Capital Partners, LP
|
|
340,536 |
|
2025-09-08 |
SCHEDULE 13G |
KZR
/ Kezar Life Sciences
|
Stonepine Capital Management, LLC
|
|
377,240 |
|
2025-09-08 |
SCHEDULE 13G |
VTVT
/ vTv Therapeutics
|
Invus Global Management, LLC
|
|
348,083 |
|
2025-09-08 |
SCHEDULE 13G |
CRNX
/ Crinetics Pharmaceuticals
|
Farallon Capital Partners, L.P.
|
|
5,625,098 |
|
2025-09-08 |
SCHEDULE 13G |
EVOK
/ Evoke Pharma
|
Morgan Stanley
|
|
163,718 |
|
2025-09-08 |
13F-HR |
GERN
/ Geron
|
Alternative Investment Advisors, LLC.
|
39,278 |
39,278 |
0.00 |
2025-09-08 |
13F-HR |
GEVO
/ Gevo
|
Alternative Investment Advisors, LLC.
|
92,780 |
73,328 |
-20.97 |
2025-09-08 |
13F-HR |
GEVO
/ Gevo
|
Alternative Investment Advisors, LLC.
|
92,780 |
92,780 |
0.00 |
2025-09-08 |
13F-HR |
GERN
/ Geron
|
Alternative Investment Advisors, LLC.
|
32,578 |
39,278 |
20.57 |
2025-09-08 |
13F-HR |
GEVO
/ Gevo
|
Alternative Investment Advisors, LLC.
|
92,780 |
92,780 |
0.00 |
2025-09-08 |
13F-HR |
GERN
/ Geron
|
Alternative Investment Advisors, LLC.
|
22,209 |
32,578 |
46.69 |
2025-09-08 |
13F-HR |
GILD
/ Gilead Sciences
|
Hoxton Planning & Management, LLC
|
3,880 |
3,883 |
0.08 |
2025-09-08 |
13F-HR |
NVO
/ Novo Nordisk A
|
Hoxton Planning & Management, LLC
|
3,678 |
3,699 |
0.57 |
2025-09-08 |
13F-HR |
LYB
/ LyondellBasell Industries N.V.
|
Hoxton Planning & Management, LLC
|
3,220 |
6,962 |
116.21 |
2025-09-08 |
13F-HR |
PG
/ Procter & Gamble
|
Hoxton Planning & Management, LLC
|
2,283 |
2,677 |
17.26 |
2025-09-08 |
13F-HR |
LLY
/ Eli Lilly and
|
Hoxton Planning & Management, LLC
|
1,358 |
1,293 |
-4.79 |
2025-09-08 |
13F-HR |
MRK
/ Merck
|
Hoxton Planning & Management, LLC
|
4,576 |
4,165 |
-8.98 |
2025-09-08 |
13F-HR |
LIN
/ Linde
|
Hoxton Planning & Management, LLC
|
985 |
915 |
-7.11 |
2025-09-08 |
13F-HR |
PFE
/ Pfizer
|
Hoxton Planning & Management, LLC
|
27,267 |
31,141 |
14.21 |
2025-09-08 |
13F-HR |
BMY
/ Bristol-Myers Squibb
|
Hoxton Planning & Management, LLC
|
|
3,665 |
|
2025-09-08 |
13F-HR |
AMGN
/ Amgen
|
Hoxton Planning & Management, LLC
|
998 |
948 |
-5.01 |
2025-09-08 |
13F-HR |
JNJ
/ Johnson & Johnson
|
Hoxton Planning & Management, LLC
|
3,461 |
3,160 |
-8.70 |
2025-09-08 |
13F-HR |
ABBV
/ AbbVie
|
Hoxton Planning & Management, LLC
|
1,830 |
2,053 |
12.19 |
2025-09-08 |
13F-HR |
BINC
/ BlackRock ETF Trust II - iShares Flexible Income Active ETF
|
Hoxton Planning & Management, LLC
|
32,275 |
33,350 |
3.33 |
2025-09-08 |
13F-HR |
AZN
/ AstraZeneca PLC - Depositary Receipt ()
|
Hoxton Planning & Management, LLC
|
2,662 |
0 |
-100.00 |
2025-09-08 |
13F-HR |
ABT
/ Abbott Laboratories
|
Hoxton Planning & Management, LLC
|
1,969 |
1,946 |
-1.17 |
2025-09-08 |
SCHEDULE 13G |
ACLX
/ Arcellx
|
T. Rowe Price Investment Management, Inc.
|
|
6,275,907 |
|
2025-09-08 |
SCHEDULE 13G/A |
RGEN
/ Repligen
|
Price T Rowe Associates Inc /md/
|
7,136,086 |
3,429,547 |
-51.94 |
2025-09-08 |
SCHEDULE 13G |
VTGN
/ Vistagen Therapeutics
|
Janus Henderson Group Plc
|
|
4,165,767 |
|
2025-09-08 |
SCHEDULE 13G |
IVVD
/ Invivyd
|
Janus Henderson Group Plc
|
|
24,271,759 |
|
2025-09-08 |
SCHEDULE 13G/A |
MOS
/ Mosaic
|
Fmr Llc
|
20,895,943 |
35,141,149 |
68.17 |
2025-09-08 |
SCHEDULE 13G/A |
PCVX
/ Vaxcyte
|
Fmr Llc
|
12,104,049 |
13,132,825 |
8.50 |
2025-09-08 |
SCHEDULE 13G/A |
AMGN
/ Amgen
|
Vanguard Group Inc
|
49,036,311 |
53,860,795 |
9.84 |
2025-09-08 |
SCHEDULE 13G/A |
SRPT
/ Sarepta Therapeutics
|
Vanguard Group Inc
|
8,816,124 |
10,641,733 |
20.71 |
2025-09-08 |
SCHEDULE 13G/A |
PG
/ Procter & Gamble
|
Vanguard Group Inc
|
224,920,035 |
235,208,844 |
4.57 |
2025-09-05 |
SCHEDULE 13D/A |
GPRE
/ Green Plains
|
Ancora Alternatives LLC
|
5,844,715 |
3,956,125 |
-32.31 |
2025-09-05 |
SCHEDULE 13D/A |
TCRT
/ Alaunos Therapeutics
|
Pmgc Capital Llc
|
83,500 |
0 |
-100.00 |
2025-09-05 |
SCHEDULE 13G/A |
EPC
/ Edgewell Personal Care
|
Brandes Investment Partners, Lp
|
4,598,440 |
5,063,875 |
10.12 |
2025-09-05 |
SCHEDULE 13D/A |
VALN
/ Valneva SE - Depositary Receipt ()
|
Bpifrance Participations SA
|
14,113,834 |
21,810,176 |
54.53 |
2025-09-05 |
SCHEDULE 13D/A |
INDV
/ Indivior
|
Two Seas Capital LP
|
11,662,308 |
10,329,152 |
-11.43 |
2025-09-05 |
13F-HR |
NTR
/ Nutrien
|
Abn Amro Investment Solutions
|
|
304,893 |
|
2025-09-05 |
13F-HR |
RXDX
/ Prometheus Biosciences
|
Abn Amro Investment Solutions
|
|
2,281 |
|
2025-09-05 |
13F-HR |
MRNA
/ Moderna
|
Abn Amro Investment Solutions
|
|
1,395 |
|
2025-09-05 |
13F-HR |
AZN
/ AstraZeneca PLC - Depositary Receipt ()
|
Abn Amro Investment Solutions
|
|
5,883 |
|
2025-09-05 |
13F-HR |
OGN
/ Organon
|
Abn Amro Investment Solutions
|
|
219,070 |
|
2025-09-05 |
13F-HR |
ABCM
/ Abcam
|
Abn Amro Investment Solutions
|
|
952,460 |
|
2025-09-05 |
13F-HR |
GILD
/ Gilead Sciences
|
Abn Amro Investment Solutions
|
|
929,358 |
|
2025-09-05 |
13F-HR |
APD
/ Air Products and Chemicals
|
Abn Amro Investment Solutions
|
|
17,342 |
|
2025-09-05 |
13F-HR |
PG
/ Procter & Gamble
|
Abn Amro Investment Solutions
|
|
791,056 |
|
2025-09-05 |
13F-HR |
BIIB
/ Biogen
|
Abn Amro Investment Solutions
|
|
1,236 |
|
2025-09-05 |
13F-HR |
LLY
/ Eli Lilly and
|
Abn Amro Investment Solutions
|
|
9,776 |
|
2025-09-05 |
13F-HR |
ABBV
/ AbbVie
|
Abn Amro Investment Solutions
|
|
10,167 |
|
2025-09-05 |
13F-HR |
ECL
/ Ecolab
|
Abn Amro Investment Solutions
|
|
168,863 |
|
2025-09-05 |
13F-HR |
PPG
/ PPG Industries
|
Abn Amro Investment Solutions
|
|
9,609 |
|
2025-09-05 |
13F-HR |
PFE
/ Pfizer
|
Abn Amro Investment Solutions
|
|
27,263 |
|
2025-09-05 |
13F-HR |
MRK
/ Merck
|
Abn Amro Investment Solutions
|
|
548,983 |
|
2025-09-05 |
13F-HR |
ONC
/ BeOne Medicines AG - Depositary Receipt ()
|
Abn Amro Investment Solutions
|
|
21,300 |
|
2025-09-05 |
13F-HR |
REGN
/ Regeneron Pharmaceuticals
|
Abn Amro Investment Solutions
|
|
17,241 |
|
2025-09-05 |
13F-HR |
IFF
/ International Flavors & Fragrances
|
Abn Amro Investment Solutions
|
|
101,356 |
|
2025-09-05 |
13F-HR |
HCM
/ HUTCHMED
|
Abn Amro Investment Solutions
|
|
99,704 |
|
2025-09-05 |
13F-HR |
DOW
/ Dow
|
Abn Amro Investment Solutions
|
|
56,693 |
|
2025-09-05 |
13F-HR |
AMGN
/ Amgen
|
Abn Amro Investment Solutions
|
|
173,290 |
|
2025-09-05 |
13F-HR |
ZTS
/ Zoetis
|
Abn Amro Investment Solutions
|
|
39,053 |
|
2025-09-05 |
13F-HR |
BMY
/ Bristol-Myers Squibb
|
Abn Amro Investment Solutions
|
|
57,619 |
|
2025-09-05 |
13F-HR |
ABT
/ Abbott Laboratories
|
Abn Amro Investment Solutions
|
|
14,164 |
|
2025-09-05 |
13F-HR |
CL
/ Colgate-Palmolive
|
Abn Amro Investment Solutions
|
|
189,853 |
|
2025-09-05 |
13F-HR |
JNJ
/ Johnson & Johnson
|
Abn Amro Investment Solutions
|
|
94,107 |
|
2025-09-05 |
13F-HR |
RPM
/ RPM International
|
Abn Amro Investment Solutions
|
|
217,841 |
|
2025-09-05 |
13F-HR |
ZLAB
/ Zai Lab Limited - Depositary Receipt ()
|
Abn Amro Investment Solutions
|
|
56,843 |
|
2025-09-05 |
13F-HR |
IDXX
/ IDEXX Laboratories
|
Abn Amro Investment Solutions
|
|
4,316 |
|
2025-09-05 |
13F-HR |
EL
/ Estée Lauder Companies
|
Abn Amro Investment Solutions
|
|
12,536 |
|
2025-09-05 |
13F-HR |
VRTX
/ Vertex Pharmaceuticals
|
Abn Amro Investment Solutions
|
|
35,199 |
|
2025-09-05 |
13F-HR |
JNJ
/ Johnson & Johnson
|
Abn Amro Investment Solutions
|
94,107 |
98,568 |
4.74 |
2025-09-05 |
13F-HR |
RXDX
/ Prometheus Biosciences
|
Abn Amro Investment Solutions
|
2,281 |
0 |
-100.00 |
2025-09-05 |
13F-HR |
RXDX
/ Prometheus Biosciences
|
Abn Amro Investment Solutions
|
|
0 |
|
2025-09-05 |
13F-HR |
MRNA
/ Moderna
|
Abn Amro Investment Solutions
|
1,395 |
0 |
-100.00 |
2025-09-05 |
13F-HR |
MRNA
/ Moderna
|
Abn Amro Investment Solutions
|
|
0 |
|
2025-09-05 |
13F-HR |
AZN
/ AstraZeneca PLC - Depositary Receipt ()
|
Abn Amro Investment Solutions
|
5,883 |
6,218 |
5.69 |
2025-09-05 |
13F-HR |
OGN
/ Organon
|
Abn Amro Investment Solutions
|
219,070 |
167,931 |
-23.34 |
2025-09-05 |
13F-HR |
PCVX
/ Vaxcyte
|
Abn Amro Investment Solutions
|
|
5,836 |
|
2025-09-05 |
13F-HR |
ABCM
/ Abcam
|
Abn Amro Investment Solutions
|
952,460 |
870,645 |
-8.59 |
2025-09-05 |
13F-HR |
PG
/ Procter & Gamble
|
Abn Amro Investment Solutions
|
791,056 |
718,760 |
-9.14 |
2025-09-05 |
13F-HR |
APD
/ Air Products and Chemicals
|
Abn Amro Investment Solutions
|
17,342 |
15,647 |
-9.77 |
2025-09-05 |
13F-HR |
GILD
/ Gilead Sciences
|
Abn Amro Investment Solutions
|
929,358 |
930,927 |
0.17 |
2025-09-05 |
13F-HR |
NTR
/ Nutrien
|
Abn Amro Investment Solutions
|
304,893 |
632,152 |
107.34 |
2025-09-05 |
13F-HR |
ONC
/ BeOne Medicines AG - Depositary Receipt ()
|
Abn Amro Investment Solutions
|
21,300 |
22,517 |
5.71 |
2025-09-05 |
13F-HR |
BIIB
/ Biogen
|
Abn Amro Investment Solutions
|
1,236 |
0 |
-100.00 |
2025-09-05 |
13F-HR |
LLY
/ Eli Lilly and
|
Abn Amro Investment Solutions
|
9,776 |
9,222 |
-5.67 |
2025-09-05 |
13F-HR |
ABBV
/ AbbVie
|
Abn Amro Investment Solutions
|
10,167 |
7,302 |
-28.18 |
2025-09-05 |
13F-HR |
ECL
/ Ecolab
|
Abn Amro Investment Solutions
|
168,863 |
151,967 |
-10.01 |
2025-09-05 |
13F-HR |
PPG
/ PPG Industries
|
Abn Amro Investment Solutions
|
9,609 |
15,840 |
64.85 |
2025-09-05 |
13F-HR |
MRK
/ Merck
|
Abn Amro Investment Solutions
|
548,983 |
428,489 |
-21.95 |
2025-09-05 |
13F-HR |
PFE
/ Pfizer
|
Abn Amro Investment Solutions
|
27,263 |
26,454 |
-2.97 |
2025-09-05 |
13F-HR |
CL
/ Colgate-Palmolive
|
Abn Amro Investment Solutions
|
189,853 |
245,574 |
29.35 |
2025-09-05 |
13F-HR |
VRTX
/ Vertex Pharmaceuticals
|
Abn Amro Investment Solutions
|
35,199 |
29,862 |
-15.16 |
2025-09-05 |
13F-HR |
REGN
/ Regeneron Pharmaceuticals
|
Abn Amro Investment Solutions
|
17,241 |
22,018 |
27.71 |
2025-09-05 |
13F-HR |
IFF
/ International Flavors & Fragrances
|
Abn Amro Investment Solutions
|
101,356 |
76,051 |
-24.97 |